Paxman proposes important change to Medicare reimbursement for mechanical scalp cooling
CMS has proposed separate reimbursement for CPT code 97008 in OPPS and MPFS for 2027, but Paxman believes the levels are insufficient and will submit comments.
See the latest news and media coverage for Paxman. We track all announcements, press releases, and industry mentions in real time, all in one place.
Scalp cooling and cryotherapy company
paxman.seLast updated
In short: Paxman achieved regulatory progress for its neuropathy system, integrated Dignitana after a merger, and expanded U.S. insurance coverage.
CMS has proposed separate reimbursement for CPT code 97008 in OPPS and MPFS for 2027, but Paxman believes the levels are insufficient and will submit comments.
The certifications include UKCA, CE, ISO 13485 and MDSAP for prevention of chemotherapy-induced peripheral neuropathy.
AB 1682 passed unanimously and moves to Appropriations Committee, thanks advocates for their efforts.
Aetna updated policy to consider scalp cooling medically necessary for eligible chemotherapy patients, naming Paxman's system.
Paxman today announces a significant regulatory milestone in the development of its Limb Cryocompression System for the reduction of chemotherapy-induced peripheral neuropathy (CIPN), with the...
Figures in parentheses refer to the outcome for the corresponding period of the previous year. Dignitana has been part of the group since June 1...
A Calderdale health innovation helping patients manage anxiety during high-stress medical treatments such as chemotherapy has won £100,000 in the Mayor's Big Ideas Challenge.
The MarketWatch News Department was not involved in the creation of this content. HOUSTON, March 12, 2026 /PRNewswire/ -- Building on statewide insurance mandates enacted...
Track Paxman and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Paxman and other trending companies.